Symbol="XCUR"
AssetType="Common Stock"
Name="Exicure Inc"
Description="Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. The company is headquartered in Chicago, Illinois."
CIK="1698530"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="8045 LAMON AVE, SUITE 410, SKOKIE, IL, US"
FiscalYearEnd="December"
LatestQuarter="2022-12-31"
MarketCapitalization="9412600"
EBITDA="-668000"
PERatio="None"
PEGRatio="None"
BookValue="3.005"
DividendPerShare="0"
DividendYield="0"
EPS="-0.6"
RevenuePerShareTTM="6.24"
ProfitMargin="-0.0896"
OperatingMarginTTM="-0.0635"
ReturnOnAssetsTTM="-0.026"
ReturnOnEquityTTM="-0.197"
RevenueTTM="28826000"
GrossProfitTTM="9059000"
DilutedEPSTTM="-0.6"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="9.28"
AnalystTargetPrice="2"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.422"
PriceToBookRatio="4.852"
EVToRevenue="21.97"
EVToEBITDA="0.126"
Beta="1.154"
num_52WeekHigh="3.24"
num_52WeekLow="0.63"
num_50DayMovingAverage="1.058"
num_200DayMovingAverage="1.179"
SharesOutstanding="8366700"
DividendDate="None"
ExDividendDate="None"
symbol="XCUR"
open="1.40"
high="1.44"
low="1.26"
price="1.36"
volume="146131.00"
latest_trading_day="2023-07-14"
previous_close="1.26"
change="0.10"
change_percent="7.9365%"
aroon_positive_momentum_days="65"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="65"
Volume_recent_avg="27962"
Change_recent_avg="0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.4"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="65"
Aroon_momentum_negative="35"
image_negative_thumbnail_id_1="512"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0093.jpeg"
image_negative_thumbnail_id_2="488"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0117.jpeg"
image_neutral_thumbnail_id_1="559"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_neutral_thumbnail_id_2="523"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_positive_thumbnail_id_1="994"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0156.jpeg"
image_positive_thumbnail_id_2="968"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0130.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
